PITTSBURGH, Oct. 19 /PRNewswire/ -- invivodata, inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, has been recognized by the Pittsburgh Technology Council in its 2009 “Tech 50" awards. This marks the fourth consecutive year that invivodata has been named a Life Sciences category finalist in the annual awards, which honor high-growth companies in southwestern Pennsylvania’s technology sector.
“We continue to be impressed with invivodata’s technological advances and leadership in the growing market for clinical research technologies,” said Audrey Russo, president and CEO, Pittsburgh Technology Council. “We applaud invivodata’s commitment to the field of life sciences and its contribution to growing and sustaining Pittsburgh’s technology industry.”
The Tech 50 awards honor those organizations that represent southwestern Pennsylvania’s most successful and innovative technology companies. The awards recognize transformative technology centers of excellence with companies at all stages of growth. invivodata was recognized for its innovations in simplifying the process of capturing valid clinical trial data from patients and its commitment to sharing with the pharmaceutical industry the knowledge it has gained in over 20 years of capturing valid and reliable PRO data electronically.
“We’re honored to once again receive Tech 50 recognition and to be considered one of Pittsburgh’s leading life sciences companies,” said Doug Engfer, invivodata President and CEO. “Our consistent sales success, financial strength, and company growth reflect our employees’ focus on and commitment to delivering real results to our pharmaceutical industry customers.”
About invivodata, inc.
invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata’s electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata’s solutions include comprehensive trial-support services that facilitate the collection of ePRO data, web-based access to study data and operational reports that give researchers and sponsors visibility into study progress, and scientific and regulatory consulting on the use of PRO data in a regulated environment. invivodata’s solution has been used in more than 275 clinical programs and is the industry-leading ePRO system in delivering primary efficacy data for FDA drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its
European headquarters are in London, England; and its technology development center is in Scotts Valley, Calif., USA. For more information visit www.invivodata.com.
SOURCE invivodata, inc.
CONTACT: Christine Tobin, Corporate Communications Specialist of
invivodata, inc., +1-412-390-3000 ext. 3502, ctobin@invivodata.com
Web site: http://www.invivodata.com/
